Amorepacific Corporation

Samsung Mobile Display Co., Ltd.

Industry-university Cooperation Foundation Hanyang University

Pacific Corporation

Joon Ho Bae

Jin Su Park

Jin Woo Park

Ji Hye Jang

Jin Kyu Choi

Min Kyung Kwon

Byong Deok Choi

Oh Kyong Kwon

Sun-Young Kim

Young-Ho Park

Yong Sung Park

Song Seok Shin

Jin Kwan Kim

Kyung Min Lim

Hyun Ju Koh

Yeon Su Jeong

Lee Kyoung Kwon

Young-Ger Suh

Ki-Wha Lee

Byung Ryol Paik

Hyeung-Geun Park

Hee-Doo Kim

Uh Taek Oh

Joo Hyun Moh

Young So Kim

Seol Rin Park

Chang Keun Lee

Chong Hyon Ryu

Sung-II Kim

Han Jin Bae

Min Kyoung Kwon

Ju A Jung

Yong-Sil Lee

Jung Ju 102-601 Dongbo Apt Kim

Disclosed is a nozzle device and a minimally invasive injection device, and the nozzle device for a minimally invasive injection device according to an exemplary embodiment includes an outlet to generate a microjet of a liquid, and an injection part of a micro-scale size connected to the outlet and adapted to be inserted into a skin tissue to a preset depth.

Nozzle device and minimally invasive injection device comprising same

One aspect of the present invention relates to an effervescent tablet comprising a water-soluble lubricating agent, and a carbonated water cosmetic composition enabled to be used together therewith. One aspect of the present invention relates to an effervescent tablet comprising a crystalline #-hydroxy acid and a water-soluble lubricating agent, and a cosmetic composition using a skin toner for preventing the tablet from floating and allowing the tablet to rapidly form carbon dioxide gas in the cosmetic composition so as to maximize the visual effect and also the effect of carbon dioxide, thereby showing skin whitening, brightening and moisturizing effects and improving the pores.

Cosmetic kit comprising effervescent tablet and skin toner

Handpiece for skin care device

Skin care device

This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. The present invention provides a pharmaceutical composition for preventing or treating a disease such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorder, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, a respiratory disorder, irritation of skin, eye or mucous membrane, stomach-duodenal ulcer, inflammatory diseases, ear disease, and heart disease.

Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same

A data driver and a method of driving the same. The data driver includes a shift register for generating sampling signals; sampling latches for sampling digital data applied to output channels, respectively, in accordance with the sampling signals; holding latch units for receiving the sampled digital data of the channels from the sampling latches to hold the digital data for a first period; first digital-to-analog converters for receiving the held digital data of the channels from the holding latch units to generate currents corresponding to the digital data; a second digital-to-analog converter commonly connected to the channels and the first digital-to-analog converters to receive the digital data provided from the holding latch units for a second period and to generate correction currents for the data currents; and output stages for sampling, correcting, and driving final currents using the data currents and the correction currents.

Data driver system and method, for use with a display device, having improved performance characteristics

Growing community of inventors

Seoul, South Korea

Joon Ho Bae